Genome Editing Selectable Marker Ratios and Digital PCR Quantification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genome editing methods face challenges in achieving high specificity and efficiency, particularly due to off-target effects and random integration, when modifying target sites in eukaryotic cells, and lack quantitative methods for evaluating knock-in efficiency.

Innovation Solution

A method involving the introduction of specific nucleic acids encoding an RNA-guided nuclease, guide RNA, and a selectable marker, with controlled ratios, followed by digital PCR using probe pairs to detect and quantify the presence of exogenous nucleic acid sequences at predetermined loci, allowing for precise selection and evaluation of modified cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If a site-specific nuclease is used to introduce DNA double-strand breaks for genome editing, then gene insertion via homologous recombination can be achieved, but off-target effects and random integration occur reducing specificity

Engineering Contradiction:
Improvegenome editing specificityVSAvoidoff-target effects and random integration
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent introduces a selectable marker gene along with the homology arm-containing nucleic acid sequence before performing homologous recombination. This preliminary action enables subsequent selection of cells that have successfully undergone targeted integration, thereby distinguishing them from cells with random integration or off-target effects, and improving genome editing specificity

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs a selection system where cells expressing the selectable marker (indicating successful targeted integration) can be identified and isolated. This feedback mechanism allows researchers to screen and select only those cells that have achieved the desired genome modification, eliminating cells with off-target effects or random integration events

Inventive Principle:
Principle #23Feedback

2Measurement precision

If conventional PCR is used to detect amplification products for confirming gene insertion, then presence of exogenous nucleic acid can be detected, but quantitativeness is lacking preventing evaluation of knock-in efficiency

Engineering Contradiction:
Improveknock-in efficiency evaluationVSAvoidquantitativeness of detection
Core Design Contradiction:
Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent replaces conventional qualitative PCR detection with digital PCR technology. Digital PCR divides the sample into numerous individual reactions, allowing absolute quantification of target nucleic acid sequences. This substitution enables precise measurement of knock-in efficiency by quantifying the ratio of edited to unedited alleles, providing the missing quantitativeness

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Manufacturing precision

If a targeting vector with homology arms is used for knock-in through homologous recombination, then gene insertion can be achieved, but the process is complex and time-consuming

Engineering Contradiction:
Improvegene insertion accuracyVSAvoidtargeting vector construction complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent segments the traditional targeting vector into separate components: a nucleic acid sequence containing only the essential homology arms and selectable marker, excluding unnecessary elements. This segmentation simplifies the construction process while maintaining the ability to achieve precise gene insertion through homologous recombination

Inventive Principle:
Principle #1Segmentation

4Object-affected harmful factors

If truncated guide RNA is used to increase specificity of genome editing, then off-target effects are reduced, but guide RNA design becomes more constrained

Engineering Contradiction:
Improveoff-target effectsVSAvoidguide RNA design flexibility
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The patent changes the parameter of guide RNA length to optimize the balance between specificity and design flexibility. By using truncated guide RNAs with reduced complementarity regions, the patent achieves lower off-target effects while the modular design approach maintains adaptability for different target sites through systematic optimization of the truncated sequences

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the specificity and efficiency of genome modifications by reducing off-target effects and random integration, while providing a quantitative method to assess knock-in efficiency, thereby improving the accuracy of genetic modifications in eukaryotic cells.

Implementation Method 1

The gRNA comprises a complementary region that binds to a DNA sequence of the target site through base-pairing

Methodology Applied
Scientific EffectBase-pairing: Chemical Bonding

Implementation Method 2

a method involving performing digital PCR on the genome as a template

Methodology Applied
Scientific EffectPCR amplification:

Implementation Method 3

detecting, via a digital PCR method, the presence or absence of hybridization, to a genomic DNA fragment derived from the chromosome, of a first probe nucleic acid that hybridizes to all or part of the nucleic acid sequence to be detected

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS20240287577A1Method for modifying target site in genome of eukaryotic cell, and method for detecting presence or absence of nucleic acid sequence to be detected at target site
Publication Date: 2024.08.29 GENAHEAD BIO INC
  • US20240287577A1 patent drawing
  • US20240287577A1 patent drawing
  • US20240287577A1 patent drawing

AI summary

Provided is a method of modifying a target site in the genome of a eukaryotic cell, the method comprising: (1) a step of introducing into the cell, introduction nucleic acids comprising (a) a template nucleic acid comprising a nucleic acid sequence encoding an RNA-guided nuclease, (b) a template nucleic acid comprising a nucleic acid sequence encoding a guide RNA, or a guide RNA, and (c) a template nucleic acid comprising a nucleic acid sequence encoding a selectable marker; and (2) a step of selecting a cell expressing the selectable marker, wherein the number of moles (C) of (c) the template nucleic acid comprising a nucleic acid sequence encoding a selectable marker, subjected to the step (1), is smaller than any of the number of moles (A) of (a) the template nucleic acid comprising a nucleic acid sequence encoding an RNA-guided nuclease and the number of moles (B) of (b) the template nucleic acid comprising a nucleic acid sequence encoding a guide RNA, or the guide RNA.